Preparation of 2-O-Arachidonoyl-1-O-stearoyl-sn-glycerol and Other Di-O-Acyl Glycerol Derivatives
作者:Piers R.J Gaffney、Colin B Reese
DOI:10.1016/s0040-4039(97)00395-x
日期:1997.4
R(-)-2,3- and S(+)-1,2-O-Isopropylidene-sn-glycerols (4 and 9) are converted into 2-O-arachidonoyl-1-O-stearoyl and 2-O-arachidonoyl-3-O-stearoyl-sn-glycerols (2 and 3, respectively); glycerol is also converted into its racemic 1,2- and its symmetrical 1,3-di-O-linoleoyl derivatives (14 and 17, respectively). (C) 1997 Elsevier Science Ltd.
Synthesis of 3,4,5-trisphosphate and its stereoisomers
作者:Piers R.J. Gaffney、Colin B. Reese
DOI:10.1016/s0960-894x(97)10166-4
日期:1997.12
The chemical synthesis of PtdIns(3,4,5)P-3 2 and three of its stereoisomers is described. (C) 1997 Elsevier Science Ltd.
UTILISATION THERAPEUTIQUE DE GLYCEROLS ACYLES ET DE LEURS ANALOGUES AZOTES ET SULFURES
申请人:Genfit
公开号:EP1596845A1
公开(公告)日:2005-11-23
[EN] THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF<br/>[FR] UTILISATION THERAPEUTIQUE DE GLYCEROLS ACYLES ET DE LEURS ANALOGUES AZOTES ET SULFURES
申请人:GENFIT
公开号:WO2004073698A1
公开(公告)日:2004-09-02
La présente invention se rapporte à l'utilisation de glycérols acylés et de leurs analogues azotés et sulfurés dans le domaine thérapeutique, notamment en santé humaine. Les composés selon l'invention possèdent des propriétés pharmacologiques avantageuses et sont notamment utilisables pour prévenir ou traiter les maladies neurodégénératives.
Total Synthesis of a Glycosylphosphatidylinositol Anchor of the Human Lymphocyte CD52 Antigen
作者:Srinivas Burgula、Benjamin M. Swarts、Zhongwu Guo
DOI:10.1002/chem.201102545
日期:2012.1.23
The first totalsynthesis of a glycosylphosphatidylinositol (GPI) anchor bearing a polyunsaturated arachidonoyl fatty acid is reported. This lipid is found in mammalian GPIs that do not undergo lipid remodeling, a process that has important implications in the localization and function of GPI‐anchored proteins. Incorporation of the oxidation‐ and reduction‐sensitive arachidonoyl lipid in the target